News Bad news for Sanofi as biosimilar replaces Lantus Pharmacy benefit firm axes Lantus, decision due on key combination therapy.
Views & Analysis Digital health round-up: Philips, artificial pancreases & mo... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Bigfoot Biomedical begins first artificial pancreas trial Trial will take place in three sites across the US.
UK & Europe AZ’s diabetes combination Qtern approved in Europe The European Commission has granted marketing approval to a new combination pill from AstraZeneca to treat type 2 diabetes.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
